Pan Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Cancer-related molecular mechanisms research 6
- NF-κB Signaling Pathways 3
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 3
- RNA Interference and Gene Delivery 2
- RNA Research and Splicing 2
- Co-authors
- Qianjin Liao (7 shared papers)Zhaoyang Zeng (6 shared papers)Bo Xiang (6 shared papers)Zhaojian Gong (4 shared papers)Ming Zhou (3 shared papers)Lei Shi (3 shared papers)Guiyuan Li (3 shared papers)Wenling Zhang (3 shared papers)
- Journals
- Oncotarget (2 papers)Cancer Management and Research (2 papers)Investigative Ophthalmology & Visual Science (1 paper)Hepatology International (1 paper)Cancer Science (1 paper)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Pan Chen
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Cancer Research 454
- Molecular Biology 569
- Oncology 160
- Immunology 94
- Epidemiology 92
Countries citing papers authored by Pan Chen
This map shows the geographic impact of Pan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Chen more than expected).
Fields of papers citing papers by Pan Chen
This network shows the impact of papers produced by Pan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Chen. The network helps show where Pan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 197 | |
| 2 | 2015 | 104 | |
| 3 | 2020 | 98 | |
| 4 | 2018 | 56 | |
| 5 | 2018 | 50 | |
| 6 | 2019 | 47 | |
| 7 | 2019 | 39 | |
| 8 | 2024 | 36 | |
| 9 | 2018 | 31 | |
| 10 | 2018 | 28 | |
| 11 | 2023 | 25 | |
| 12 | 2019 | 25 | |
| 13 | 2023 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2017 | 19 | |
| 16 | 2025 | 19 | |
| 17 | 2024 | 18 | |
| 18 | 2023 | 18 | |
| 19 | 2022 | 17 | |
| 20 | 2024 | 15 |
About Pan Chen
Pan Chen is a scholar working on Cancer Research, Molecular Biology, Endocrinology, Oncology and Pharmacology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), NF-κB Signaling Pathways (3 papers), RNA modifications and cancer (3 papers), RNA Interference and Gene Delivery (2 papers), RNA Research and Splicing (2 papers), Plant and Fungal Interactions Research (2 papers) and Metal complexes synthesis and properties (2 papers). The work is most often cited by research in Cancer Research (454 citations), Molecular Biology (569 citations), Oncology (160 citations), Immunology (94 citations) and Epidemiology (92 citations). Pan Chen has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Qianjin Liao, Zhaoyang Zeng, Bo Xiang, Zhaojian Gong, Ming Zhou, Lei Shi, Guiyuan Li, Wenling Zhang, Xiayu Li and Wei Xiong. Their work appears in journals such as Oncotarget, Cancer Management and Research, Investigative Ophthalmology & Visual Science, Hepatology International and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.